Parmax Pharma Limited has intimated the postponement of its Board of Directors meeting to the BSE Limited.
The meeting, which was originally scheduled for Friday, November 13, 2026, has been postponed due to unavoidable circumstances. It has been rescheduled to be held on Saturday, November 14, 2026.
The agenda for the rescheduled board meeting includes two items:
- To consider and approve the unaudited financial results for the quarter and half year ended September 30, 2026.
- To consider shifting of the Registered Office of the Company.
The intimation is signed by Umang Gosalia, Managing Director (DIN: 05153830), and was digitally signed on November 13, 2026, at 18:38:58 IST. This communication serves as a follow-up to an earlier intimation dated November 10, 2026.